
The U.S. federal government will pay drugmaker Sanofi and GlaxoSmithKline approximately $2.1 billion to develop and provide 100 million dosages of their potential coronavirus vaccine, the business revealed Friday.
… [+3044 chars]
The U.S. federal government will pay drugmaker Sanofi and GlaxoSmithKline approximately $2.1 billion to develop and provide 100 million dosages of their potential coronavirus vaccine, the business revealed Friday.
… [+3044 chars]